We have located links that may give you full text access.
CASE REPORTS
COMPARATIVE STUDY
JOURNAL ARTICLE
The use of occluding tinted contact lenses.
CLAO Journal : Official Publication of the Contact Lens Association of Ophthalmologists, Inc 1998 April
PURPOSE: We explored the clinical issues surrounding the use of tinted contact lenses for vision occlusion in cases of debilitating vision disturbance, such as intractable diplopia.
METHODS: We report the results with four patients fit with occluding tinted contact lenses.
RESULTS: Vision occlusion by contact lenses provided a suitable comfortable occlusion method with improved cosmesis compared to occlusion by spectacles. Lens parameters and tint specifications were ordered for each patient. Correct lens care and handling were necessary to avoid contact lens related ocular inflammation.
CONCLUSION: Provided that lens care is satisfactory and the patient does not have unreasonable expectations, a tinted contact lens can be a useful alternative to a covered spectacle lens or eye patch when occluding one eye, such as in cases of intractable diplopia, severe vision distortion, or intolerable photophobia.
METHODS: We report the results with four patients fit with occluding tinted contact lenses.
RESULTS: Vision occlusion by contact lenses provided a suitable comfortable occlusion method with improved cosmesis compared to occlusion by spectacles. Lens parameters and tint specifications were ordered for each patient. Correct lens care and handling were necessary to avoid contact lens related ocular inflammation.
CONCLUSION: Provided that lens care is satisfactory and the patient does not have unreasonable expectations, a tinted contact lens can be a useful alternative to a covered spectacle lens or eye patch when occluding one eye, such as in cases of intractable diplopia, severe vision distortion, or intolerable photophobia.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app